🇺🇸 Oral Electrolytes in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Respiratory Failure — 1 report (10%)
  2. Altered State Of Consciousness — 1 report (10%)
  3. Anaemia — 1 report (10%)
  4. Asthenia — 1 report (10%)
  5. Atelectasis — 1 report (10%)
  6. Bronchial Obstruction — 1 report (10%)
  7. Bronchial Secretion Retention — 1 report (10%)
  8. Calculus Ureteric — 1 report (10%)
  9. Catheter Site Haematoma — 1 report (10%)
  10. Constipation — 1 report (10%)

Source database →

Oral Electrolytes in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Oral Electrolytes approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Oral Electrolytes in United States?

Universidad de Colima is the originator. The local marketing authorisation holder may differ — check the official source linked above.